Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ELV · against 44 other Healthcare companies of similar size
Ranked #10 of 45 · scores higher than 80% of peers
Bars: peers in each 10-point band of the valuation score6 peers with a valuation score of 70–79, including ELV · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | ELV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 43 reported | 5.5% | 3.2% | 81% | 30% | |
| EBITDA yieldHigher is better · 46 reported | 10.0% | 6.3% | 80% | 50% | |
| Free cash flow yieldHigher is better · 35 reported | 7.0% | 3.9% | 82% | 20% | |
| Book yieldHigher is better · 42 reported | 50.0% | 19.9% | 90% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 92 | 71 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 108.6B USD | 88 | 66 | |
| 4 | 97.5B USD | 87 | 67 | |
| 5 | 45.9B USD | 84 | 61 | |
| 6 | 126.1B USD | 83 | 62 | |
| 6 | 540.4B BRL (≈$97.3B) | 83 | 64 | |
| 8 | 162.93T ARS (≈$162.9B) | 82 | 63 | |
| 8 | 100.2B USD | 82 | 57 | |
| 10 | 89.7B USD | 76 | 50 | |
| 11 | 63.0B USD | 74 | 65 | |
| 12 | 534.1B HKD (≈$68.4B) | 72 | 75 | |
| 12 | 48.5B EUR (≈$53.4B) | 72 | 53 | |
| 14 | 11.26T JPY (≈$76.6B) | 71 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score